Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 13, 2015

S100B protein concentration measurement according to two different immunoassays

Joffrey Feriel, Fréderic Adamo, Denis Monneret, Virginie Trehel-Tursis, Séverine Favard, Chantal Tsé, Louis Puybasset, Dominique Bonnefont-Rousselot and Françoise Imbert-Bismut

Corresponding author: Françoise Imbert-Bismut, AP-HP, Hôpital Pitié-Salpêtrière, Service de Biochimie Métabolique, Paris, 75013, France, E-mail:


We thank Roche Diagnostics for technical assistance and providing reagents free of charge.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


1. Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, et al. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 2012;9: 209–18.10.1016/j.annemergmed.2011.07.027Search in Google Scholar

2. Sanchez-Peña P, Pereira AR, Sourour NA, Biondi A, Lejean L, Colonne C, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008;36:2267–73.10.1097/CCM.0b013e3181809750Search in Google Scholar

3. Ruan S, Noyes K, Bazarian JJ. The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. J Neurotrauma 2009;26:1655–64.10.1089/neu.2009.0928Search in Google Scholar

4. Cervellin G, Benatti M, Carbucicchio A, Mattei L, Cerasti D, Aloe R, et al. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clin Biochem 2012;45:408–11.10.1016/j.clinbiochem.2012.01.006Search in Google Scholar

5. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739–44.10.1016/0006-291X(65)90320-7Search in Google Scholar

6. Ohrt-Nissen S, Friis-Hansen L, Dahl B, Stensballe J, Romner B, Rasmussen LS. How does extracerebral trauma affect the clinical value of S100B measurements? Emerg Med J 2011;28:941–4.10.1136/emj.2010.091363Search in Google Scholar PubMed PubMed Central

7. Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644–59.10.1111/j.1471-4159.2011.07612.xSearch in Google Scholar PubMed

8. Einav S, Itshayek E, Kark JD, Ovadia H, Weiniger CF, Shoshan Y. Serum S100B levels after meningioma surgery: a comparison of two laboratory assays. BMC Clin Pathol 2008;8:9.10.1186/1472-6890-8-9Search in Google Scholar PubMed PubMed Central

9. Laribi S, Kansao J, Borderie D, Collet C, Deschamps P, Ababsa R, et al. S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study. Clin Chem Lab Med 2014;52:527–36.10.1515/cclm-2013-0621Search in Google Scholar PubMed

10. White GH, Farrance I. Uncertainty of measurement in quantitative medical testing – a laboratory implementation guide. Clin Biochem Rev 2004;25:S1–24.Search in Google Scholar

11. Beaudeux JL, Léger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ. Influence of haemolysis on the measurement of S-100β protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 2000;46:989–90.10.1093/clinchem/46.7.989Search in Google Scholar

Received: 2014-11-6
Accepted: 2015-1-5
Published Online: 2015-2-13
Published in Print: 2015-6-1

©2015 by De Gruyter